Amphastar Sanctioned For Veiling Docs Over Blood Thinner IP

Law360, Los Angeles (December 5, 2013, 5:32 PM EST) -- A Massachusetts federal judge on Thursday hit Amphastar Pharmaceuticals Inc. with sanctions for disobeying discovery requests in Momenta Pharmaceuticals Inc.’s patent suit against Amphastar over production of generic versions of the blood thinner Lovenox, finding that Amphastar’s refusal to turn over documents violated court orders.

U.S. Magistrate Judge Robert B. Collings ruled that Amphastar’s behavior was “quite serious and possibly contumacious” in not handing over unredacted versions of its Abbreviated New Drug Application and other correspondence with the U.S. Food and Drug Administration. But even though...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.